Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st
Aditx Therapeutics(ADTX) GlobeNewswire News Room·2024-07-25 21:00
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer, will present and host one-on-one meetings at the OTCQB Venture Virtual Investor Conference as follows: Date:Thursday, August 1, 2024Time:10:30am ETAccess Webcast:(live and archive)https://bit.ly/3LySuJNor archive: https://evofem.investorroom.com/events Durin ...